CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Xiangxue Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Xiangxue Pharmaceutical Co Ltd
No.2
Jinfengyuan Road, Science City
Phone: +86 2022211007p:+86 2022211007 GUANGZHOU, GNG  510663  China Ticker: 300147300147
Business Summary
Xiangxue Pharmaceutical Co Ltd is a China-based company engaged in the research, development, production and distribution of traditional Chinese medicines and herbal decoction pieces. The Company operates five segments. The Pharmaceutical Manufacturing segment produces pharmaceutical products, including Chinese patent medicines (antiviral oral liquid, indigowoad root granules and Exocarpium Citri Reticulatae series), Chinese herbal medicines, and chemical medicines. The chemical medicines are used in oral and pharyngeal inflammation, hypertension, angina pectoris, colds and fevers. The Pharmaceutical Distribution segment is engaged in the distribution of Chinese herbal medicines, pharmaceutical markets, and blood products. The Medical Device segment mainly produces Baiyun medical glue and Gaoxun medical catheters. The Others segment includes T-cell immunotherapy, used to treat tumors and liver cancer. The Company distributes its products in domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries
3842 Orthopedic, prosthetic, and surgical appliances and supplies
3841 Surgical and medical instruments and apparatus
2086 Bottled and canned soft drinks and carbonated waters

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager YonghuiWang 60 6/25/2007 1/1/1997
Chief Financial Officer FengLu 49 6/28/2019 6/28/2019
Chief Technical Research and Development officer LunZeng 53 1/1/2016 5/27/2013
8 additional Officers and Directors records available in full report.

Business Names
Business Name
300147
Xiangxue Pharmaceutical Co Ltd

General Information
Number of Employees: 2,644 (As of 12/31/2023)
Outstanding Shares: 661,279,045 (As of 9/30/2024)
Shareholders: 49,641
Stock Exchange: SHE
Fax Number: +86 2022211018


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 19, 2025